Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581542 · ClinicalTrials.gov registry record · Phase 4
Moxifloxacin vs. Polytrim for Conjunctivitis
A Phase 4 study of Conjunctivitis, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT00581542 is a Phase 4 study of Conjunctivitis that has completed, run by University of Rochester. The registered enrollment target is 124 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00581542, a Phase 4 study of Conjunctivitis, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
Conditions Studied
Interventions
- DRUG moxifloxacin
- DRUG polytrim
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581542
The ClinicalTrials.gov registry entry for NCT00581542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Conjunctivitis appearing as the primary indexed condition, and to 2 interventions - of which moxifloxacin is the first listed.
NCT00581542 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00581542 about?
NCT00581542 is a clinical study titled "Moxifloxacin vs. Polytrim for Conjunctivitis". The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of t...
What is the current status of trial NCT00581542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2007-03. Estimated completion is 2012-03.
What conditions does trial NCT00581542 study?
This clinical trial studies the following conditions: Conjunctivitis.
What interventions are being tested in trial NCT00581542?
The interventions under investigation include: moxifloxacin (DRUG), polytrim (DRUG).
Who is sponsoring clinical trial NCT00581542?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581542 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Conjunctivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.